The current valuation score of Coherus BioSciences Inc is 8.81, ranking 68 out of 158 in the Pharmaceuticals industry. Its current P/E ratio is 0.81, which is 723.34% below the recent high of 6.67 and 5283.18% above the recent low of -41.99.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.